It has been demonstrated that ANGPTL4 was expressed at higher levels in the blood of breast cancer patients [136] and high expression of ANGPTL4 correlated with a minor disease-free survival of breast cancer young patients [137]. Here, ANGPTL4 is linked to breast carcinoma.